Septerna, Inc. Cash Flow Statement
SEPN / Health Care|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Septerna, Inc. generated $110M in operating cash flow and $110M in free cash flow in FY2025. Free cash flow margin was 238.7% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$48.9M | $4.2M | $4.2M |
| Depreciation & Amortization | $1.6M | $800.0K | $800.0K |
| Operating Cash Flow | $110.2M | -$38.7M | -$38.7M |
| Capital Expenditures | $518.0K | $2.9M | $2.9M |
| Free Cash Flow | $109.7M | -$41.6M | -$41.6M |
| FCF Margin | 238.7% | -27550.3% | - |